Cargando…
Fucoidan antagonizes diet-induced obesity and inflammation in mice
Obesity is an escalating global pandemic posing a serious threat to human health. The intervention therapy using weight-reducing drugs, accompanied by lifestyle modification, is a strategy for the treatment of obesity. In the present study, we explored the role of fucoidan, a seaweed compound, on hi...
Autores principales: | Wang, Lei, Zhang, Kun, Ding, Xin, Wang, Yan, Bai, Hui, Yang, Qing, Ben, Jingjing, Zhang, Hanwen, Li, Xiaoyu, Chen, Qi, Zhu, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193708/ https://www.ncbi.nlm.nih.gov/pubmed/33495425 http://dx.doi.org/10.7555/JBR.34.20200153 |
Ejemplares similares
-
Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK–NF-κB signaling mediated inflammation
por: Ben, Jingjing, et al.
Publicado: (2019) -
Pharmacological antagonism of the incretin system protects against diet-induced obesity
por: Svendsen, Berit, et al.
Publicado: (2019) -
Gpr97 is dispensable for metabolic syndrome but is involved in macrophage inflammation in high-fat diet-induced obesity in mice
por: Shi, Jueping, et al.
Publicado: (2016) -
Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway
por: Fang, Ru, et al.
Publicado: (2016) -
Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans
por: Zhang, Wei, et al.
Publicado: (2015)